Therapeutics Ocumension - Dec 5, 2023 Form 4 Insider Report for EyePoint Pharmaceuticals, Inc. (EYEP)

Role
Director
Signature
/s/ Ye Liu
Stock symbol
EYEP
Transactions as of
Dec 5, 2023
Transactions value $
-$19,510,637
Form type
4
Date filed
12/7/2023, 09:21 PM
Next filing
Jan 16, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EYEP common stock Sale -$14.6M -734K -24.37% $19.91 2.28M Dec 5, 2023 Direct
transaction EYEP common stock Sale -$4.9M -266K -11.69% $18.41 2.01M Dec 6, 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.80 to $20.38. The reporting person undertakes to provide EyePoint Pharmaceuticals Inc., any security holder of EyePoint Pharmaceuticals Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. 2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.17 to $18.49. The reporting person undertakes to provide EyePoint Pharmaceuticals Inc., any security holder of EyePoint Pharmaceuticals Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.